How many drugs treat Prevention of opioid abuse?

Drug Landscape tracks 4 marketed treatments for Prevention of opioid abuse (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/prevention-of-opioid-abuse.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Prevention of opioid abuse — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of opioid abuse (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of opioid abuse, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Subutex	Buprenorphine Hydrochloride	Indivior	partial opioid agonist	mu-opioid receptor, kappa-opioid receptor	1981-01-01
Subutex	BUPRENORPHINE	Purdue Pharma Lp	Partial Opioid Agonist	mu-opioid receptor, kappa-opioid receptor	1981-01-01
Narcan	NALOXONE	Adapt	Opioid Antagonist	Mu-type opioid receptor	1971-01-01
Naltrexon	Naltrexon	Institute of Liver and Biliary Sciences, India		Neuronal acetylcholine receptor subunit alpha-7, Cytochrome P450 2D6, Delta-type opioid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Adapt · 1 drug in Prevention of opioid abuse
Indivior · 1 drug in Prevention of opioid abuse
Institute of Liver and Biliary Sciences, India · 1 drug in Prevention of opioid abuse
Purdue Pharma Lp · 1 drug in Prevention of opioid abuse

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of opioid abuse:

Cite this brief

Drug Landscape (2026). Prevention of opioid abuse — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-opioid-abuse. Accessed 2026-06-10.

Prevention of opioid abuse full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing